Guardian Pharmacy Services, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
GRDN$49.85+6.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity
| (In thousands, except share amounts) · Class A Shares · Class B Shares · Class A Amount · Class B Amount · Additional Paid-in capital · Retained Earnings · Non-Controlling Interests · Total Equity | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance, December 31, 2025 | 36,253,744 | 27,066,890 | $36 | $27 | $139,353 | $66,343 | $12,165 | $217,924 | ||||||
| Contributions | — | — | — | — | — | — | 79 | 79 | ||||||
| Distributions | — | — | — | — | — | — | (960) | (960) | ||||||
| Net income attributable to Guardian Pharmacy Services, Inc. | — | — | — | — | — | 13,295 | — | 13,295 | ||||||
| Net income attributable to non-controlling interest | — | — | — | — | — | — | 249 | 249 | ||||||
| Share-based compensation forfeitures | — | — | — | — | (47) | — | — | (47) | ||||||
| Share-based compensation expense | — | — | — | — | 1,794 | — | — | 1,794 | ||||||
| Conversion of Class B Common Stock to Class A Common Stock | 13,527,437 | (13,527,437) | 14 | (14) | — | — | — | — | ||||||
| Other | $90 | $90 | ||||||||||||
| Balance, March 31, 2026 | 49,781,181 | 13,539,453 | $50 | $13 | $141,190 | $79,638 | $11,533 | $232,424 | ||||||
| (In thousands, except share amounts) | Class A Shares | Class B Shares | Class A Amount | Class B Amount | Additional Paid-in capital | Retained Earnings | Non-Controlling Interests | Total Equity | ||||||
| Balance, December 31, 2024 | 9,200,000 | 54,087,158 | $9 | $54 | $125,484 | $17,124 | $7,305 | $149,976 | ||||||
| Contributions | — | — | — | — | — | — | 135 | 135 | ||||||
| Distributions | — | — | — | — | — | — | (135) | (135) | ||||||
| Net income attributable to Guardian Pharmacy Services, Inc. | — | — | — | — | — | 9,448 | — | 9,448 | ||||||
| Net income (loss) attributable to non-controlling interest | — | — | — | — | — | — | (175) | (175) | ||||||
| Share-based compensation forfeitures | — | (516) | — | — | (1) | — | — | (1) | ||||||
| Share-based compensation expense | — | — | — | — | 3,969 | — | — | 3,969 | ||||||
| Conversion of Class B Common Stock to Class A Common Stock | 13,519,946 | (13,519,946) | 14 | (14) | — | — | — | — | ||||||
| Balance, March 31, 2025 | 22,719,946 | 40,566,696 | $23 | $40 | $129,452 | $26,572 | $7,130 | $163,217 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.